Diisononyl phthalate


Curated chemical-disease associations from CTD
Disease IDDisease nameReference
MESH:D000015 Abnormalities, Multiple PMID:36921846
MESH:D001836 Body Weight Changes PMID:36921846
MESH:D002471 Cell Transformation, Neoplastic PMID:31154059
MESH:D003876 Dermatitis, Atopic PMID:20064775
MESH:D004485 Eczema PMID:29398652
MESH:D004487 Edema PMID:27863430
MESH:D005234 Fatty Liver PMID:29933238
MESH:D005832 Genital Diseases, Male PMID:22112501
MESH:D006059 Gonadal Dysgenesis PMID:25445723
MESH:D006332 Cardiomegaly PMID:30940551
MESH:D006529 Hepatomegaly PMID:29991372
MESH:D006967 Hypersensitivity PMID:27863430
MESH:D006973 Hypertension PMID:30940551
MESH:D009845 Oligospermia PMID:36921846
MESH:D011297 Prenatal Exposure Delayed Effects PMID:25353625; PMID:25445723
MESH:D011658 Pulmonary Fibrosis PMID:29758289
MESH:D012130 Respiratory Hypersensitivity PMID:29758289
MESH:D012734 Disorders of Sex Development PMID:36921846
MESH:D015430 Weight Gain PMID:29991372; PMID:30802670
MESH:D015674 Mammary Neoplasms, Animal PMID:34428494
MESH:D017449 Dermatitis, Allergic Contact PMID:27863430; PMID:28240277
MESH:D056486 Chemical and Drug Induced Liver Injury PMID:29933238

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.